Cargando…

Effect of Food and Dosing Regimen on Safety and Efficacy of Proton Pump Inhibitors Therapy—A Literature Review

Proton pump inhibitors (PPIs) are the first-choice drugs used to prevent and treat acid-related diseases. However, a lack of satisfactory response to the standard PPI dose (“PPI failure”) is often reported, especially in patients with gastroesophageal reflux disease. Poor compliance seems to be one...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiesner, Agnieszka, Zwolińska-Wcisło, Małgorzata, Paśko, Paweł
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036504/ https://www.ncbi.nlm.nih.gov/pubmed/33805341 http://dx.doi.org/10.3390/ijerph18073527

Ejemplares similares

Optimal Dosing Regimen of Osteoporosis Drugs in Relation to Food Intake as the Key for the Enhancement of the Treatment Effectiveness—A Concise Literature Review
por: Wiesner, Agnieszka, et al.
Publicado: (2021)

How to Optimize the Effectiveness and Safety of Parkinson’s Disease Therapy? – A Systematic Review of Drugs Interactions with Food and Dietary Supplements
por: Agnieszka, Wiesner, et al.
Publicado: (2022)

Levothyroxine Interactions with Food and Dietary Supplements–A Systematic Review
por: Wiesner, Agnieszka, et al.
Publicado: (2021)

Intestinal parameters of oxidative imbalance in celiac adults with extraintestinal manifestations
por: Piatek-Guziewicz, Agnieszka, et al.
Publicado: (2017)

Association between Fecal Short-Chain Fatty Acid Levels, Diet, and Body Mass Index in Patients with Inflammatory Bowel Disease
por: Dąbek-Drobny, Agnieszka, et al.
Publicado: (2022)

Fecal Levels of Lactic, Succinic and Short-Chain Fatty Acids in Patients with Ulcerative Colitis and Crohn Disease: A Pilot Study
por: Kaczmarczyk, Olga, et al.
Publicado: (2021)

A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
por: Dipasquale, Valeria, et al.
Publicado: (2022)

Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment for Helicobacter pylori
por: Lim, Hyun Chul, et al.
Publicado: (2014)

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
por: Ikemura, Kenji, et al.
Publicado: (2017)

Application of the Clustering Technique to Multiple Nutritional Factors Related to Inflammation and Disease Progression in Patients with Inflammatory Bowel Disease
por: Dąbek-Drobny, Agnieszka, et al.
Publicado: (2022)

The Importance of Nutritional Aspects in the Assessment of Inflammation and Intestinal Barrier in Patients with Inflammatory Bowel Disease
por: Kaczmarczyk, Olga, et al.
Publicado: (2022)

Interactions of Antiretroviral Drugs with Food, Beverages, Dietary Supplements, and Alcohol: A Systematic Review and Meta-analyses
por: Wiesner, Agnieszka, et al.
Publicado: (2022)

Proton Pump Inhibitors and Oncologic Treatment Efficacy: A Practical Review of the Literature for Oncologists
por: Uchiyama, Angel A. T., et al.
Publicado: (2021)

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents
por: Kakiuchi, Toshihiko
Publicado: (2023)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

The Safety of Long-term Daily Usage of a Proton Pump Inhibitor: A Literature Review
por: Abbas, Mohammed K, et al.
Publicado: (2019)

Efficacy, safety and cost-effectiveness of vonoprazan vs Proton Pump Inhibitors in reflux disorders and H. pylori eradication: A literature review
por: Shehryar, Muhammad, et al.
Publicado: (2022)

Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence
por: Mistry, Suresh D., et al.
Publicado: (2011)

High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis
por: Zhu, Zhenhua, et al.
Publicado: (2021)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021)

Efficacy of Low Dose Proton Pump Inhibitor-Based Therapy to Eradicate Helicobacter pylori in Patients with Subtotal Gastrectomy
por: Kim, Dongwoo, et al.
Publicado: (2019)

Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux
por: Liu, C., et al.
Publicado: (2016)

Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia
por: Wauters, Lucas, et al.
Publicado: (2021)

Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma
por: Homicsko, Krisztian, et al.
Publicado: (2022)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
por: Hsieh, Yu-Hsi, et al.
Publicado: (2013)

Pharmacoeconomic Analysis of Fixed-Dose Combinations of Proton Pump Inhibitors Available in India
por: Deolekar, Pradnya, et al.
Publicado: (2023)

Efficacy and Safety of Direct-acting Antivirals in Hepatitis C Virus-infected Patients Taking Proton Pump Inhibitors
por: Wijarnpreecha, Karn, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature
por: Briganti, Silvia Irina, et al.
Publicado: (2021)

The risk of essential fatty acid insufficiency in patients with inflammatory bowel diseases: fatty acid profile of phospholipids in serum and in colon biopsy specimen
por: Bugajska, Jolanta, et al.
Publicado: (2022)

The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis
por: Chen, Lingxiao, et al.
Publicado: (2016)

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
por: Vonkeman, Harald, et al.
Publicado: (2010)

Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
por: Snady, Harry
Publicado: (2023)

Impact of Proton Pump Inhibitor Therapy on the Efficacy of Clopidogrel in the CAPRIE and CREDO Trials
por: Dunn, Steven P., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_29mqn8t2ahnhfrg8kpot4je9f7